(piperidin-4-yl)methyl 4-fluoro-4-(hydroxymethyl)piperidine-1-carboxylate hydrochloride, 97.0%, 250mg

Polytungstate de sodium hydraté, min 99,9 %, pa, 250 g, emballage plastique.

2-(3-Aminopropoxy)naphthalene, 95%, 250mg

3-Ethylcyclobutane-1-carboxylic acid, 98+%, 1g

(E)-3-(4-Fluorophenyl)-2-methylacrylic acid, 97%, 100mg

1-((R)-3-Hydroxy-pyrrolidin-1-yl)-ethanone, 95.0%, 25g

6-Bromo-2-methylimidazo[1,2-a]pyrazine, 95.0%, 1g

1-Methyl-1H-indazol-5-yl-5-boronic acid, 97.0%, 250mg

2-(((6-(Difluoromethoxy)-1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-3,4-dimethoxypyridine 1-oxide, 95.00%, 50mg

Objectif Plan S40x/0,65 corrigé à l'infini

3-bromo-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyridine, 95.0%, 500mg

3-methyl-4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)isoxazol-5-amine, 95.0%, 500mg

5-[(4-methoxyphenyl)methoxy]-2-nitro-aniline, 97%, 500mg